FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a pharmaceutical composition of sedative and spasmolytic action. Pharmaceutical composition is presented in the form of a tablet or capsule and contains dry valerian extract, dry extract motherwort, dry extract of hawthorn fruits, dry mint extract, mint oil, melatonin, lactose monohydrate, microcrystalline cellulose, aerosil and magnesium stearate in amounts specified in the claim. As biologically active substances, the composition contains flavonoids in amount of 0.0190 ± 0.0008 wt% in terms of rutin.
EFFECT: as described above, thecomposition has a more convenient solid dosage form and has a more pronounced therapeutic effect in treating hyperthyroidism and panic attacks accompanied by tachycardia.
3 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
| ANTISPASMODIC, DIURETIC AND ANTI-INFLAMMATORY DRUG (VERSIONS) | 2024 |
|
RU2836881C1 |
| PHYTOMIXTURE WITH SEDATIVE EFFECT | 2013 |
|
RU2554796C2 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| DIMEXIDE GEL POSSESSING ANTI-INFLAMMATORY ACTION | 2024 |
|
RU2838731C1 |
| ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
| MEDICATION BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD OF OBTAINING THEREOF (VERSIONS) | 2012 |
|
RU2563190C2 |
| COMPOSITION FOR TOPICAL APPLICATION IN THE TREATMENT OF ONYCHOMYCOSIS (OPTIONS) | 2022 |
|
RU2786851C1 |
| DRUG WITH SPASMOLITHIC, DIURETIC AND LITHIOLIC ACTION | 2017 |
|
RU2635459C1 |
| METHOD FOR PRODUCTION OF PLANT-ORIGIN PHARMACEUTICAL AGENT OF SEDATIVE ACTION | 2004 |
|
RU2281111C2 |
